Creo Medical announced plans to sell its remaining 49% stake in its European division to the division's CEO, with the deal expected to complete within three months pending approvals. The company also plans to raise approximately £5.5 million through a share placing at a 31.9% premium, with directors and the Development Bank of Wales subscribing significant amounts. Full-year 2025 results showed strong revenue growth and reduced losses, and the company expects 2026 revenue growth between 50% and 60%. The stake sale and fundraising aim to simplify the group, strengthen the balance sheet, and fund the company until it reaches sustainable cash flow and profitability.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
The U.S. Patent and Trademark Office (USPTO) has introduced an AI-assisted image search feature in its public trademark search system, TM Search, using technology from Clarivate Plc. This new tool allows users to upload images and compare them agains...
Experian PLC started its 2027 financial year with a 10% revenue increase in the first quarter, driven by strong demand in North America and Latin America. Organic growth was 7%, with North America growing 7% despite a 2% drop in consumer services due...
Gooch & Housego, a UK-listed photonics company specializing in precision optics for aerospace and defence, has agreed to a £345.6 million takeover by US private equity firm Arlington Capital Partners. The offer values the company at a 41.3% premium t...
Aave DAO has proposed an innovative mobile app that integrates fiat currency deposits, self-custody, and decentralized finance (DeFi) lending in one platform. This app allows users to convert fiat to stablecoins and earn yields without needing extern...
